Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Macquarie Maintains Neutral on Paramount Global, Lowers Price Target to $15

Macquarie Maintains Neutral on Paramount Global, Lowers Price Target to $15

Macquarie analyst Tim Nollen maintains Paramount Global (NASDAQ:PARA) with a Neutral and lowers the price target from $16 to $15.

byBenzinga Newsdesk

January 4, 2023

1 minute read

Macquarie analyst Tim Nollen maintains Paramount Global (NASDAQ:PARA) with a Neutral and lowers the price target from $16 to $15.

Analyst Ratings

What 7 Analyst Ratings Have To Say About Stoke Therapeutics

By Benzinga Insights

April 26, 2:00 PM

Over the past 3 months, 7 analysts have published their opinion on Stoke Therapeutics (NASDAQ:STOK) stock. These analysts…

STOK

News

Why Aramark Stock Is Diving

By Henry Khederian

August 10, 10:20 AM

Aramark (NYSE: ARMK) shares are trading lower by 4.1% to $39.72 Thursday morning after the company announced pricing of a secondary offering of common stock.

ARMK

Canaccord Genuity Assumes Plug Power at Hold, Announces Price Target of $16

By Benzinga Newsdesk

October 21, 9:22 AM

Canaccord Genuity analyst George Gianarikas assumes Plug Power (NASDAQ:PLUG) with a Hold rating and announces Price Target of $16.

PLUG

RBC Capital Maintains Outperform on BRP, Raises Price Target to C$124

By Benzinga Newsdesk

December 1, 8:34 AM

RBC Capital analyst Joseph Spak maintains BRP (TSX:DOO) with a Outperform and raises the price target from C$114 to C$124.

DOOO

Macquarie Maintains Neutral on Paramount Global, Lowers Price Target to $15

Related Posts

What 7 Analyst Ratings Have To Say About Stoke Therapeutics

Why Aramark Stock Is Diving

Canaccord Genuity Assumes Plug Power at Hold, Announces Price Target of $16

RBC Capital Maintains Outperform on BRP, Raises Price Target to C$124